Quantifying selection against synonymous mutations in HIV-1 env evolution

Journal of Virology

Volumn 87, Issue 21, 2013, Pages 11843-11850

  Zanini, Fabio ^a   Neher, Richard A ^a  

^a MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ACYLATION; ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; GENE FREQUENCY; GENE MUTATION; GENETIC DRIFT; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE VARIANT; VIRUS ENVELOPE; VIRUS MUTATION; CONFORMATION; GENETIC SELECTION; GENETICS; HUMAN; LONGITUDINAL STUDY; MISSENSE MUTATION; MOLECULAR EVOLUTION;

ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; EVOLUTION, MOLECULAR; HIV-1; HUMANS; LONGITUDINAL STUDIES; MUTATION, MISSENSE; NUCLEIC ACID CONFORMATION; RNA, VIRAL; SELECTION, GENETIC;

EID: 84925558761     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01529-13     Document Type: Article

References (48)

1. Rambaut A, Posada D, Crandall KA, Holmes EC. 2004. The causes and consequences of HIV evolution. Nat. Rev. Genet. 5:52-61.
2. Mansky LM, Temin HM. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
3. Abram ME, Ferris AL, Shao W, Alvord WG, Hughes SH. 2010. Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J. Virol. 84:9864-9878.
4. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10:11-23.
5. Richman DD, Wrin T, Little SJ, Petropoulos CJ. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. U. S. A. 100:4144-4149.
6. Bhatt S, Holmes EC, Pybus OG. 2011. The genomic rate of molecular adaptation of the human influenza A virus. Mol. Biol. Evol. 28:2443-2451.
7. Hurst LD. 2002. The Ka/Ks ratio: diagnosing the form of sequence evolution. Trends Genet. 18:486-487.
8. Chen L, Perlina A, Lee CJ. 2004. Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase. J. Virol. 78:3722-3732.
9. Fernandes J, Jayaraman B, Frankel A. 2012. The HIV-1 rev response element: anRNAscaffold that directs the cooperative assembly of a homooligomeric ribonucleoprotein complex. RNA Biol. 9:4-9.
10. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW, Jr, Swanstrom R, Burch CL, Weeks KM. 2009. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 460:711-716.
11. Keating CP, Hill MK, Hawkes DJ, Smyth RP, Isel C, Le S-Y, Palmenberg AC, Marshall JA, Marquet R, Nabel GJ, Mak J. 2009. The A-rich RNA sequences of HIV-1 pol are important for the synthesis of viral cDNA. Nucleic Acids Res. 37:945-956.
12. Forsdyke DR. 1995. Reciprocal relationship between stem-loop potential and substitution density in retroviral quasispecies under positive Darwinian selection. J. Mol. Evol. 41:1022-1037.
13. Snoeck J, Fellay J, Bartha I, Douek DC, Telenti A. 2011. Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints. Retrovirology 8:87.
14. Pollom E, Dang KK, Potter EL, Gorelick RJ, Burch CL, Weeks KM, Swanstrom R. 2013. Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and nonconserved structural motifs. PLoS Pathog. 9:e1003294. doi:10.1371/journal.ppat.1003294.
15. Neher RA, Leitner T. 2010. Recombination rate and selection strength in HIV intra-patient evolution. PLoS Comput. Biol. 6:e1000660. doi:10.1371/journal.pcbi.1000660.
16. Batorsky R, Kearney MF, Palmer SE, Maldarelli F, Rouzine IM, Coffin JM. 2011. Estimate of effective recombination rate and average selection coefficient for HIV in chronic infection. Proc. Natl. Acad. Sci. U. S. A. 108:5661-5666.
17. Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang X-L, Mullins JI. 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489-10502.
18. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, Wong K, McLaughlin S, McSweyn MD, Diem K, Stevens CE, Maenza J, He H, Nickle DC, Shriner D, Holte SE, Collier AC, Corey L, McElrath JM, Mullins JI. 2006. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J. Virol. 80:9519-9529.
19. Bunnik EM, Pisas L, Van Nuenen AC, Schuitemaker H. 2008. Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection. J. Virol. 82:7932-7941.
20. Kuiken C, Leitner T, Hahn B, Mullins J, Wolinsky S, Foley B, Apetrei C, Mizrachi I, Rambaut A, Korber B. 2012. HIV sequence compendium. Los Alamos National Laboratory, Los Alamos, NM.
21. Edgar RC. 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32:1792-1797.
22. Zanini F, Neher RA. 2012. FFPopSim: an efficient forward simulation package for the evolution of large populations. Bioinformatics 28:3332-3333.
23. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
24. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, Perelson AS, Ho DD. 2003. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77:5037-5038.
25. Levy DN, Aldrovandi GM, Kutsch O, Shaw GM. 2004. Dynamics of HIV-1 recombination in its natural target cells. Proc. Natl. Acad. Sci. U. S. A. 101:4204-4209.
26. + T-cells contain one HIV-1 DNA molecule. PLoS Pathog. 9:e1003432. doi:10.1371/journal.ppat.1003432.
27. Boltz VF, Ambrose Z, Kearney MF, Shao W, KewalRamani VN, Maldarelli F, Mellors JW, Coffin JM. 2012. Ultrasensitive allele-specific PCR reveals rare preexisting drug-resistant variants and a large replicating virus population in macaques infected with a simian immunodeficiency virus containing human immunodeficiency virus reverse transcriptase. J. Virol. 86:12525-12530.
28. Neher RA, Shraiman B. 2011. Genetic draft and quasi-neutrality in large facultatively sexual populations. Genetics 188:975-996.
29. Asquith B, Edwards CTT, Lipsitch M, McLean AR. 2006. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 4:e90. doi:10.1371/journal.pbio.0040090.
30. Moore PL, Ranchobe N, Lambson BE, Gray ES, Cave E, Abrahams M-R, Bandawe G, Mlisana K, Abdool Karim SS, Williamson C, Morris L, CAPRISA 002 study, NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI). 2009. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection. PLoS Pathog. 5:e1000598. doi:10.1371/journal.ppat.1000598.
31. McKay MD, Beckman RJ, Conover WJ. 1979. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics 21:239-245.
32. Coffin JM. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
33. Sanjuan R, Borderia AV. 2011. Interplay between RNA structure and protein evolution in HIV-1. Mol. Biol. Evol. 28:1333-1338.
34. Jenkins GM, Holmes EC. 2003. The extent of codon usage bias in human RNA viruses and its evolutionary origin. Virus Res. 92:1-7.
35. van der Kuyl AC, Berkhout B. 2012. The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus. Retrovirology 9:92.
36. Williamson S. 2003. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol. Biol. Evol. 20:1318-1325.
37. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.
38. Smith JM, Haigh J. 1974. The hitch-hiking effect of a favourable gene. Genet. Res. 23:23-35.
39. Gillespie JH. 2000. Genetic drift in an infinite population. The pseudohitchhiking model. Genetics 155:909-919.
40. Bar KJ, Tsao C-Y, Iyer SS, Decker JM, Yang Y, Bonsignori M, Chen X, Hwang K-K, Montefiori DC, Liao H-X, Hraber P, Fischer W, Li H, Wang S, Sterrett S, Keele BF, Ganusov VV, Perelson AS, Korber BT, Georgiev I, McLellan JS, Pavlicek JW, Gao F, Haynes BF, Hahn BH, Kwong PD, Shaw GM. 2012. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog. 8:e1002721. doi:10.1371/journal.ppat.1002721.
41. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, Leitner T, Han CS, Gleasner CD, Green L, Lo C-C, Nag A, Wallstrom TC, Wang S, McMichael AJ, Haynes BF, Hahn BH, Perelson AS, Borrow P, Shaw GM, Bhattacharya T, Korber BT. 2010. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultradeep sequencing. PLoS One 5:e12303. doi:10.1371/journal.pone.0012303.
42. Hedskog C, Mild M, Jernberg J, Sherwood E, Bratt G, Leitner T, Lundeberg J, Andersson B, Albert J. 2010. Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLoS One 5:e11345. doi:10.1371/journal.pone.0011345.
43. Knoepfel SA, Berkhout B. 2013. On the role of four small hairpins in the HIV-1 RNA genome. RNA Biol. 10:512-524.
44. Mayrose I, Doron-Faigenboim A, Bacharach E, Pupko T. 2007. Towards realistic codon models: among site variability and dependency of synonymous and non-synonymous rates. Bioinformatics 23:i319 -i327.
45. Ngandu NK, Scheffler K, Moore P, Woodman Z, Martin D, Seoighe C. 2008. Extensive purifying selection acting on synonymous sites in HIV-1 group M sequences. Virol. J. 5:160.
46. Ferguson AL, Mann JK, Omarjee S, Ndung'u T, Walker BD, Chakraborty AK. 2013. Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design. Immunity 38:606-617.
47. + T cells from peripheral blood of HIV-1 infected individuals contain only one HIV DNA molecule. Proc. Natl. Acad. Sci. U. S. A. 108:11199-11204.
48. Nijhuis M, Boucher CAB, Schipper P, Leitner T, Schuurman R, Albert J. 1998. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. Proc. Natl. Acad. Sci. U. S. A. 95: 14441-14446.